Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval of Triumeq

July 1, 2014

Bevacizumab recommended for E.U. approval in new indication

July 1, 2014

EMA committee hands down positive opinion on Eylea for DME

July 1, 2014

EMA committee recommends approval of Abasria

June 30, 2014

EMA's CHMP recommends new approval for Eliquis

June 30, 2014

Bristol-Myers Squibb receives positive CHMP opinion for Daklinza

June 30, 2014

Vizamyl recommended for approval in E.U.

June 30, 2014

Regorafenib recommended for approval in Europe for GIST

June 30, 2014

Vertex receives positive CHMP opinion to expand Kalydeco approval

June 30, 2014

EMA accepts Ravicti MAA

June 26, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026